•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

S08334 Summary:

BILL NOS08334
 
SAME ASNo Same As
 
SPONSORGOUNARDES
 
COSPNSR
 
MLTSPNSR
 
Amd §§3216, 3221 & 4303, Ins L; amd §365-a, Soc Serv L
 
Requires insurance reimbursement for vaccination for severe acute respiratory syndrome coronavirus 2.
Go to top

S08334 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          8334
 
                               2025-2026 Regular Sessions
 
                    IN SENATE
 
                                      June 3, 2025
                                       ___________
 
        Introduced by Sen. GOUNARDES -- read twice and ordered printed, and when
          printed to be committed to the Committee on Rules
 
        AN  ACT  to  amend  the  insurance  law  and the social services law, in
          relation to insurance reimbursement for vaccination for  severe  acute
          respiratory syndrome coronavirus 2

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Clause  (iii)  of  subparagraph  (B)  of  paragraph  17  of
     2  subsection (i) of section 3216 of the insurance law, as amended by chap-
     3  ter 219 of the laws of 2011, is amended to read as follows:
     4    (iii)  necessary immunizations, as determined by the superintendent in
     5  consultation with the commissioner of health,  consisting  of  at  least
     6  adequate  dosages of vaccine against diphtheria, pertussis, severe acute
     7  respiratory syndrome coronavirus 2, tetanus,  polio,  measles,  rubella,
     8  mumps,  haemophilus  influenzae  type  b and hepatitis b, which meet the
     9  standards approved by the United States public health service  for  such
    10  biological products.
    11    § 2. Clause (iii) of subparagraph (B) of paragraph 8 of subsection (l)
    12  of  section  3221 of the insurance law, as amended by chapter 219 of the
    13  laws of 2011, is amended to read as follows:
    14    (iii) necessary immunizations, as determined by the superintendent  in
    15  consultation  with  the  commissioner  of health, consisting of at least
    16  adequate dosages of vaccine against diphtheria, pertussis, severe  acute
    17  respiratory  syndrome  coronavirus  2, tetanus, polio, measles, rubella,
    18  mumps, haemophilus influenzae type b and hepatitis  b,  which  meet  the
    19  standards  approved  by the United States public health service for such
    20  biological products.
    21    § 3. Subparagraph (C) of paragraph 2 of subsection (j) of section 4303
    22  of the insurance law, as amended by chapter 219 of the laws of 2011,  is
    23  amended to read as follows:

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD13303-01-5

        S. 8334                             2
 
     1    (C)  necessary  immunizations,  as determined by the superintendent in
     2  consultation with the commissioner of health,  consisting  of  at  least
     3  adequate  dosages of vaccine against diphtheria, pertussis, severe acute
     4  respiratory syndrome coronavirus 2, tetanus,  polio,  measles,  rubella,
     5  mumps,  haemophilus  influenzae  type  b and hepatitis b, which meet the
     6  standards approved by the United States public health service  for  such
     7  biological products.
     8    §  4.  Paragraph  (v)  of subdivision 2 of section 365-a of the social
     9  services law, as added by section 4 of part B of chapter 58 of the  laws
    10  of 2010, is amended to read as follows:
    11    (v)  administration  of  vaccinations, consisting of at least adequate
    12  dosages of vaccine against diphtheria, pertussis, severe  acute  respir-
    13  atory  syndrome  coronavirus 2, tetanus, polio, measles, rubella, mumps,
    14  haemophilus influenzae type b and hepatitis b, which meet the  standards
    15  approved  by the United States public health service for such biological
    16  products, in a pharmacy by a certified pharmacist within  [his  or  her]
    17  their scope of practice.
    18    § 5. This act shall take effect on the first of January after it shall
    19  have  become  a law and shall apply to any contract entered into, deliv-
    20  ered, amended or modified on or after the date it takes effect.
Go to top